|
3TNP
Structure and Allostery of the PKA RIIb Tetrameric Holoenzyme
Deposited 2011-09-01
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain B
1–416(416 aa)
Chain E
1–416(416 aa)
|
Mutation:R230K
Mutation:R230K
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7.5;298 K;The RII (R230K)2:C2 holoenzyme complex was crystallized at room temperature in 10% PEG8000, 8% ethylene glycol, pH7.5 HEPES buffer by using vapor diffusion at a 1:1 ratio of protein to crystallization solution. VAPOR DIFFUSION, HANGING DROP, temperature 298K
|
Resolution 2.30 Å
R-free 0.235
|
|
3TNP
Structure and Allostery of the PKA RIIb Tetrameric Holoenzyme
Deposited 2011-09-01
|
Different mutation/modification
Different ligand/ion
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain B
1–416(416 aa)
|
Mutation:R230K
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7.5;298 K;The RII (R230K)2:C2 holoenzyme complex was crystallized at room temperature in 10% PEG8000, 8% ethylene glycol, pH7.5 HEPES buffer by using vapor diffusion at a 1:1 ratio of protein to crystallization solution. VAPOR DIFFUSION, HANGING DROP, temperature 298K
|
Resolution 2.30 Å
R-free 0.235
|
|
3TNP
Structure and Allostery of the PKA RIIb Tetrameric Holoenzyme
Deposited 2011-09-01
|
Different mutation/modification
Different ligand/ion
Different structure-quality metrics
|
Assembly 3
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain E
1–416(416 aa)
|
Mutation:R230K
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7.5;298 K;The RII (R230K)2:C2 holoenzyme complex was crystallized at room temperature in 10% PEG8000, 8% ethylene glycol, pH7.5 HEPES buffer by using vapor diffusion at a 1:1 ratio of protein to crystallization solution. VAPOR DIFFUSION, HANGING DROP, temperature 298K
|
Resolution 2.30 Å
R-free 0.235
|
|
4WBB
Single Turnover Autophosphorylation Cycle of the PKA RIIb Holoenzyme
Deposited 2014-09-02
|
Different mutation/modification
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain A
1–416(416 aa)
|
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
CA CALCIUM ION × 2
ADP ADENOSINE-5'-DIPHOSPHATE × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
BATCH MODE;298 K;The RIIb (R230K):C apo complex was crystallized in 20%PEG8000, 8% Ethylene Glycol, 20mM MESpH7.5 HEPES . To make CaATP binding holoenzyme crystals, the apo holoenzyme crystals were soaked with 20%PEG8000, 8% Ethylene Glycol, 20mM MESpH7.5 HEPES, 5mM CaCl2 and 1mM ATP at pH5.8 solution overnight
|
Resolution 2.80 Å
R-free 0.279
|
|
4X6Q
An Isoform-specific Myristylation Switch Targets RIIb PKA Holoenzymes to Membranes
Deposited 2014-12-08
|
Different mutation/modification
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain B
1–416(416 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
BATCH MODE;298 K;The RIIb(R230K)2: myrC(K7C)2 holoenzyme
was concentrated to 12 mg/mL. The crystal used for structure determination was obtained from a 3 uL drop containing 1:1 protein to well solution with the well solution containing 10% PEG8000, 8% ethylene glycol, 20mM MES, at pH5.8.
|
Resolution 2.52 Å
R-free 0.261
|